Logo image of MIME

MIMECAST LTD (MIME) Stock Fundamental Analysis

NASDAQ:MIME - Nasdaq - GB00BYT5JK65 - Common Stock

79.92  +0.03 (+0.04%)

After market: 79.96 +0.04 (+0.05%)

Fundamental Rating

3

MIME gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 283 industry peers in the Software industry. MIME may be in some trouble as it scores bad on both profitability and health. MIME is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year MIME was profitable.
MIME Yearly Net Income VS EBIT VS OCF VS FCFMIME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M 40M 60M 80M 100M

1.2 Ratios

Industry RankSector Rank
ROA 4.46%
ROE 9.31%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MIME Yearly ROA, ROE, ROICMIME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 5 -5 -10

1.3 Margins

Industry RankSector Rank
OM 10.57%
PM (TTM) 8.22%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MIME Yearly Profit, Operating, Gross MarginsMIME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 40 60

3

2. Health

2.1 Basic Checks

MIME has more shares outstanding than it did 1 year ago.
MIME has a better debt/assets ratio than last year.
MIME Yearly Shares OutstandingMIME Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M
MIME Yearly Total Debt VS Total AssetsMIME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M

2.2 Solvency

MIME has an Altman-Z score of 6.77. This indicates that MIME is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.14 indicates that MIME is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 6.77
ROIC/WACCN/A
WACCN/A
MIME Yearly LT Debt VS Equity VS FCFMIME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.58 indicates that MIME should not have too much problems paying its short term obligations.
MIME has a Quick Ratio of 1.58. This is a normal value and indicates that MIME is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
MIME Yearly Current Assets VS Current LiabilitesMIME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.29% over the past year.
The Earnings Per Share has been growing by 89.07% on average over the past years. This is a very strong growth
MIME shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.43%.
The Revenue has been growing by 28.74% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)35.29%
EPS 3Y110.31%
EPS 5Y89.07%
EPS Q2Q%15.15%
Revenue 1Y (TTM)19.43%
Revenue growth 3Y24.17%
Revenue growth 5Y28.74%
Sales Q2Q%16.98%

3.2 Future

MIME is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.84% yearly.
MIME is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.88% yearly.
EPS Next Y26.07%
EPS Next 2Y18.97%
EPS Next 3Y18.71%
EPS Next 5Y16.84%
Revenue Next Year19.27%
Revenue Next 2Y17.64%
Revenue Next 3Y17.66%
Revenue Next 5Y16.88%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MIME Yearly Revenue VS EstimatesMIME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
MIME Yearly EPS VS EstimatesMIME Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5 2 2.5

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 57.91, the valuation of MIME can be described as expensive.
Compared to an average S&P500 Price/Earnings ratio of 29.62, MIME is valued quite expensively.
With a Price/Forward Earnings ratio of 49.10, MIME can be considered very expensive at the moment.
When comparing the Price/Forward Earnings ratio of MIME to the average of the S&P500 Index (22.70), we can say MIME is valued expensively.
Industry RankSector Rank
PE 57.91
Fwd PE 49.1
MIME Price Earnings VS Forward Price EarningsMIME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 49.94
MIME Per share dataMIME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MIME does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as MIME's earnings are expected to grow with 18.71% in the coming years.
PEG (NY)2.22
PEG (5Y)0.65
EPS Next 2Y18.97%
EPS Next 3Y18.71%

0

5. Dividend

5.1 Amount

MIME does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MIMECAST LTD

NASDAQ:MIME (5/18/2022, 8:00:01 PM)

After market: 79.96 +0.04 (+0.05%)

79.92

+0.03 (+0.04%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-03 2022-02-03/amc
Earnings (Next)06-03 2022-06-03/bmo
Inst Owners0.02%
Inst Owner Change0%
Ins Owners0.43%
Ins Owner Change0%
Market Cap5.35B
Analysts69.41
Price Target82.53 (3.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 57.91
Fwd PE 49.1
P/S 9.3
P/FCF N/A
P/OCF N/A
P/B 10.54
P/tB N/A
EV/EBITDA 49.94
EPS(TTM)1.38
EY1.73%
EPS(NY)1.63
Fwd EY2.04%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.59
BVpS7.59
TBVpSN/A
PEG (NY)2.22
PEG (5Y)0.65
Profitability
Industry RankSector Rank
ROA 4.46%
ROE 9.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 10.57%
PM (TTM) 8.22%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z 6.77
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.29%
EPS 3Y110.31%
EPS 5Y89.07%
EPS Q2Q%15.15%
EPS Next Y26.07%
EPS Next 2Y18.97%
EPS Next 3Y18.71%
EPS Next 5Y16.84%
Revenue 1Y (TTM)19.43%
Revenue growth 3Y24.17%
Revenue growth 5Y28.74%
Sales Q2Q%16.98%
Revenue Next Year19.27%
Revenue Next 2Y17.64%
Revenue Next 3Y17.66%
Revenue Next 5Y16.88%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A